5-Methyl-7-methoxyisoflavone
CAT:
804-HY-N1993-01
Size:
10 mg
For Laboratory Research Only. Not for Clinical or Personal Use.
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


5-Methyl-7-methoxyisoflavone
UNSPSC Description:
5-Methyl-7-methoxyisoflavone is an orally active anti-oxidant with remyelinating activity. 5-Methyl-7-methoxyisoflavone inhibits the enzyme aromatase, interfering with the normal metabolic pathways of testosterone. 5-Methyl-7-methoxyisoflavone is a non-steroidal anabolic isoflavone, used as a anabolic agent. 5-Methyl-7-methoxyisoflavone shows better potency increasing muscle mass and endurance than Ipriflavone (HY-N0094). 5-Methyl-7-methoxyisoflavone can be used for fat loss besides the maintenance of low cholesterol level and strengthen bones[1][2][3].Target Antigen:
Cytochrome P450Type:
Natural ProductsRelated Pathways:
Metabolic Enzyme/ProteaseApplications:
Metabolism-protein/nucleotide metabolismField of Research:
Metabolic DiseaseAssay Protocol:
https://www.medchemexpress.com/5-methyl-7-methoxyisoflavone.htmlPurity:
99.78Solubility:
DMSO : 125 mg/mL (ultrasonic)Smiles:
O=C1C(C2=CC=CC=C2)=COC3=CC(OC)=CC(C)=C13Molecular Weight:
266.29References & Citations:
[1]Ningbo Gong, et al. Concomitant polymorphs of methoxyflavone (5-methyl-7-methoxyflavone). RSC Adv., 2016, 6, 38709-38715.|[2]Agresti C, et al. Oxidative status in multiple sclerosis and off-targets of antioxidants: the case of edaravone[J]. Current Medicinal Chemistry, 2020, 27(13): 2095-2105.|[3]Iannone M, et al. An investigation on the metabolic pathways of synthetic isoflavones by gas chromatography coupled to high accuracy mass spectrometry. Rapid Commun Mass Spectrom. 2019 Oct 15;33(19):1485-1493. |[4]Lecompte Y, et al. UPLC-ESI-Q-TOF-MS(E) identification of urinary metabolites of the emerging sport nutrition supplement methoxyisoflavone in human subjects. J Pharm Biomed Anal. 2014 Aug 5;96:127-34.Shipping Conditions:
Room TemperatureStorage Conditions:
-20°C, 3 years; 4°C, 2 years (Powder)Clinical Information:
No Development ReportedCAS Number:
82517-12-2
